Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003325305 | SCV004294643 | uncertain significance | not provided | 2023-03-11 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 221292). This variant has been observed in individual(s) with clinical features of hereditary spastic paraplegia (PMID: 26437029). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant, c.2490_2492del, results in the deletion of 1 amino acid(s) of the HACE1 protein (p.Leu832del), but otherwise preserves the integrity of the reading frame. |
OMIM | RCV000207174 | SCV000262623 | pathogenic | Spastic paraplegia-severe developmental delay-epilepsy syndrome | 2016-02-04 | no assertion criteria provided | literature only | |
Molecular Genetics laboratory, |
RCV003325305 | SCV004031399 | pathogenic | not provided | 2021-05-31 | no assertion criteria provided | clinical testing |